Citadel Advisors’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.2K Sell
171,200
-100
-0.1% -$157 ﹤0.01% 12358
2025
Q4
$531K Buy
171,300
+82,200
+92% +$235K ﹤0.01% 8880
2025
Q3
$234K Buy
89,100
+31,700
+55% +$69.9K ﹤0.01% 10890
2025
Q2
$70.6K Sell
57,400
-400
-0.7% -$436 ﹤0.01% 11580
2025
Q1
$63.6K Sell
57,800
-23,300
-29% -$26.9K ﹤0.01% 12041
2024
Q4
$73.4K Buy
81,100
+28,800
+55% +$24.7K ﹤0.01% 11904
2024
Q3
$51.6K Sell
52,300
-5,900
-10% -$5.68K ﹤0.01% 11872
2024
Q2
$52.4K Buy
58,200
+50,400
+646% +$37.7K ﹤0.01% 11706
2024
Q1
$9.2K Buy
7,800
+2,300
+42% +$2.53K ﹤0.01% 13514
2023
Q4
$5.02K Sell
5,500
-700
-11% -$517 ﹤0.01% 13464
2023
Q3
$5.16K Sell
6,200
-3,800
-38% -$4.38K ﹤0.01% 13417
2023
Q2
$12K Sell
10,000
-31,300
-76% -$39K ﹤0.01% 13105
2023
Q1
$52K Sell
41,300
-63,100
-60% -$121K ﹤0.01% 12096
2022
Q4
$227K Buy
104,400
+78,500
+303% +$646K ﹤0.01% 9895
2022
Q3
$310K Buy
+25,900
New +$321K ﹤0.01% 9499
2022
Q2
Sell
-36,200
Closed -$314K 13320
2022
Q1
$314K Buy
36,200
+20,900
+137% +$202K ﹤0.01% 10492
2021
Q4
$173K Buy
+15,300
New +$182K ﹤0.01% 12068
2021
Q3
Sell
-259,700
Closed -$2.11M 14103
2021
Q2
$2.11M Sell
259,700
-400
-0.2% -$3.47K ﹤0.01% 6484
2021
Q1
$2.41M Buy
260,100
+222,300
+588% +$2.24M ﹤0.01% 5966
2020
Q4
$366K Buy
37,800
+7,200
+24% +$70.9K ﹤0.01% 8723
2020
Q3
$380K Buy
30,600
+17,900
+141% +$237K ﹤0.01% 7754
2020
Q2
$165K Buy
12,700
+900
+8% +$11.3K ﹤0.01% 8673
2020
Q1
$120K Sell
11,800
-49,200
-81% -$642K ﹤0.01% 8492
2019
Q4
$953K Sell
61,000
-211,800
-78% -$4.27M ﹤0.01% 5672
2019
Q3
$4.58M Buy
+272,800
New +$5.42M ﹤0.01% 3236

Other funds holding GOSS